BIM deletion polymorphism profiling complements prognostic values of risk scores in imatinib-treated Asian chronic myeloid leukemia patients

Clinical prognostic scores have been integral to risk assessment and therapeutic decision making in patients with hematological malignancies. The Sokal, Hasford and European Treatment and Outcome S...